Arm 1 Standard of care

2 trials

Sponsors

Stop TB Partnership, National Institute of Allergy and Infectious Diseases

Conditions

Tuberculosis

Phase 2

A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis (RAD-TB)

Active, not recruitingPACTR202404734179820

National Institute of Allergy and Infectious DiseasesTuberculosis

Start: 2024-04-01Target: 100Updated: 2026-09-14

Unknown Phase

''Ubumi Bwandi” TB Infection Trial

Active, not recruitingPACTR202402859908544

Stop TB PartnershipTuberculosis

Start: 2024-02-05Target: 2900Updated: 2026-09-14